Source: 4-TRADERS

Naurex: Allergan : Successfully Completes Naurex Acquisition

(4-traders.com) DUBLIN, Aug. 31, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system,...http://www.4-traders.com/ALLERGAN-INC-11564/news/Allergan--Successfully-Completes-Naurex-Acquisition-21017321/

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Norbert G. Riedel's photo - President & CEO of Naurex

President & CEO

Norbert G. Riedel

CEO Approval Rating

68/100

Read more